FindTrial
Sign In

comparison of acyclovir and bleomycin injection in treatment of warts

A comparative study of efficacy of intra-lesional Bleomycin versus intra-lesional Acyclovir in management of warts

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044451
Enrollment
100
Registered
2022-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B079- Viral wart, unspecified

Interventions

Intervention1: Injection acyclovir 70mg/ml intralesional: Intralesional acyclovir injection at 0, 4 weeks. total of 2 injections Control Intervention1: Injection bleomycin 1mg/ml intralesional: Intral

Sponsors

Military hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18-60 years with clinical diagnosis of warts

Exclusion criteria

Exclusion criteria: 1.Patients below the age of 18 years and above the age of 60 years. 2.Patients not willing to participate in the study. 3.Pregnant or lactating females. 4. Patients with any systemic illness 5. Patient with history of treatment of warts in last 6 months 7.Patients having hypersensitivity to bleomycin or acyclovir

Design outcomes

Primary

MeasureTime frame
clinical resolution of wartsTimepoint: clinical resolution of warts at 24 weeks—

Secondary

MeasureTime frame
patient satisfaction scoreTimepoint: at presentation and 6 months after treatment—

Countries

India

Contacts

Public ContactEeshaan ranjan

military hospital jammu

eeshaan.ranjan@gmail.com9720639323

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026